Results 261 to 270 of about 1,614,566 (371)

An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma.

open access: yesBlood, 2012
R. Vij   +23 more
semanticscholar   +1 more source

Optimization of a reactor for biostimulant production with emphasis on the economic aspects of hydrolysis

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Abstract Biostimulants are increasingly used in agriculture to promote plant growth, improve stress tolerance, and support sustainable farming practices. One common method of production is chemical hydrolysis of protein‐rich waste, such as tannery by‐products, offering an economical and eco‐friendly alternative to conventional raw materials.
Karel Kolomazník   +3 more
wiley   +1 more source

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

open access: green, 2011
Ian McGowan   +9 more
openalex   +2 more sources

On subset least squares estimation and prediction in vector autoregressive models with exogenous variables

open access: yesCanadian Journal of Statistics, EarlyView.
Abstract We establish the consistency and the asymptotic distribution of the least squares estimators of the coefficients of a subset vector autoregressive process with exogenous variables (VARX). Using a martingale central limit theorem, we derive the asymptotic normal distribution of the estimators. Diagnostic checking is discussed using kernel‐based
Pierre Duchesne   +2 more
wiley   +1 more source

Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors. [PDF]

open access: yesNature
Singh S   +58 more
europepmc   +1 more source

Higher electronic health record burden among women physicians in academic ambulatory medicine. [PDF]

open access: yesJAMIA Open
Bessen SY   +7 more
europepmc   +1 more source

Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
With the increasing volume of clinical evidence derived from large‐scale Asian real‐world data (RWD) and the growing interest in its use in regulatory decision‐making, it is important to conduct benchmarking exercises that evaluate whether studies using Asian RWD can generate similar conclusions as randomized controlled trials (RCTs).
Hwa Yeon Ko   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy